# Evaluation of Hydrocortisone, Vitamin C and Thiamine for the Treatment of Septic Shock

> **NCT03380507** · PHASE2,PHASE3 · TERMINATED · sponsor: **Hamad Medical Corporation** · enrollment: 106 (actual)

## Conditions studied

- Septic Shock
- Critical Illness

## Interventions

- **DRUG:** Triple therapy group

## Key facts

- **NCT ID:** NCT03380507
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-03-17
- **Primary completion:** 2019-10-03
- **Final completion:** 2021-11-01
- **Target enrollment:** 106 (ACTUAL)
- **Why stopped:** The research is no longer funded and terminated due to futility
- **Last updated:** 2021-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03380507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03380507, "Evaluation of Hydrocortisone, Vitamin C and Thiamine for the Treatment of Septic Shock". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03380507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*